Department of Biology
Vittoria Raffa has not added Biography.
If you are Vittoria Raffa and would like to personalize this page please email our Author Liaison for assistance.
Zinc oxide nanoparticles as selective killers of proliferating cells.
International journal of nanomedicine , 2011 | Pubmed ID: 21698081
Generation of magnetized olfactory ensheathing cells for regenerative studies in the central and peripheral nervous tissue.
International journal of molecular sciences May, 2013 | Pubmed ID: 23708092
Growth factor choice is critical for successful functionalization of nanoparticles.
Frontiers in neuroscience , 2015 | Pubmed ID: 26388717
pdzrn3 is required for pronephros morphogenesis in Xenopus laevis.
The International journal of developmental biology , 2016 | Pubmed ID: 26934292
A catechin nanoformulation inhibits WM266 melanoma cell proliferation, migration and associated neo-angiogenesis.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V May, 2017 | Pubmed ID: 28088004
Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy.
Current neuropharmacology , 2018 | Pubmed ID: 28714394
Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress.
Cellular and molecular life sciences : CMLS Apr, 2018 | Pubmed ID: 29098325
Nano-topography: Quicksand for cell cycle progression?
Nanomedicine : nanotechnology, biology, and medicine Nov, 2018 | Pubmed ID: 30010000
Conformal coating by multilayer nano-encapsulation for the protection of human pancreatic islets: In-vitro and in-vivo studies.
Nanomedicine : nanotechnology, biology, and medicine 10, 2018 | Pubmed ID: 30016718
Piconewton Mechanical Forces Promote Neurite Growth.
Biophysical journal Nov, 2018 | Pubmed ID: 30473016
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy.
Frontiers in bioengineering and biotechnology , 2020 | Pubmed ID: 32158755
A Model of a Zebrafish Avatar for Co-Clinical Trials.
Cancers Mar, 2020 | Pubmed ID: 32183229
Extremely Low Forces Induce Extreme Axon Growth.
The Journal of neuroscience : the official journal of the Society for Neuroscience Jun, 2020 | Pubmed ID: 32444384
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine.
World journal of gastroenterology Jun, 2020 | Pubmed ID: 32550755
Manipulation of Axonal Outgrowth via Exogenous Low Forces.
International journal of molecular sciences Oct, 2020 | Pubmed ID: 33126477
Induction of Axonal Outgrowth in Mouse Hippocampal Neurons via Bacterial Magnetosomes.
International journal of molecular sciences Apr, 2021 | Pubmed ID: 33923565
Toxicological Profile of Plasmonic Nanoparticles in Zebrafish Model.
International journal of molecular sciences Jun, 2021 | Pubmed ID: 34198694
Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients.
Cancers Aug, 2021 | Pubmed ID: 34439284
Magnetically-actuated microposts stimulate axon growth.
Biophysical journal Feb, 2022 | Pubmed ID: 34979131
Effects of Metal Oxide Nanoparticles in Zebrafish.
Oxidative medicine and cellular longevity , 2022 | Pubmed ID: 35154565
Force: A messenger of axon outgrowth.
Seminars in cell & developmental biology May, 2023 | Pubmed ID: 35817654
Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients.
Biomedicines Jun, 2022 | Pubmed ID: 35884780
CRISPR/Cas9 in the era of nanomedicine and synthetic biology.
Drug discovery today Jan, 2023 | Pubmed ID: 36174966
Axonal plasticity in response to active forces generated through magnetic nano-pulling.
Cell reports Jan, 2023 | Pubmed ID: 36640304
Neuroprotective Nanoparticles Targeting the Retina: A Polymeric Platform for Ocular Drug Delivery Applications.
Pharmaceutics Mar, 2023 | Pubmed ID: 37111581
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유